Salkind Gene bought UPXI
July 11, 2025 · Form 4 insider transaction
Salkind Gene bought 20,243 shares of Upexi, Inc. at $4.94 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
20,243
Price
$4.94
Total value
$100.0K
InsiderSalkind Gene
RoleDirector
CompanyUpexi, Inc. (UPXI)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 11, 2025
Filing dateJuly 30, 2025
Shares owned after385,370
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.